Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BG Medicine's Total Stockholders Equity for the quarter that ended in Dec. 2015 was $-1.98 Mil. BG Medicine's Total Assets for the quarter that ended in Dec. 2015 was $2.13 Mil.
Therefore, BG Medicine's Equity to Asset Ratio for the quarter that ended in Dec. 2015 was -0.93.
The historical rank and industry rank for BG Medicine's Equity-to-Asset or its related term are showing as below:
BGMD's Equity-to-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.65 * Ranked among companies with meaningful Equity-to-Asset only.
BG Medicine Equity-to-Asset Historical Data
The historical data trend for BG Medicine's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BG Medicine's Equity-to-Asset
For the Medical Instruments & Supplies subindustry, BG Medicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BG Medicine's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where BG Medicine's Equity-to-Asset falls into.
BG Medicine Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
BG Medicine's Equity to Asset Ratio for the fiscal year that ended in Dec. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BG Medicine (OTCPK:BGMD) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
BG Medicine Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of BG Medicine's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGMD has been successfully added to your 